-
Product Insights
New![]()
Net Present Value Model: Stealth BioTherapeutics Corp’s Elamipretide hydrochloride
Overview Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – LQ-036 in Asthma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.LQ-036 in AsthmaDrug Details: LQ-036 antibody is under development for the treatment of asthma and chronic...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – SBT-272 in Ischemia Reperfusion Injury
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.SBT-272 in Ischemia Reperfusion InjuryDrug Details:SBT-272 is under development for the treatment of ischemia reperfusion kidney...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – XTX-202 in Metastatic Melanoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.XTX-202 in Metastatic Melanoma Drug Details:XTX-202 is under development for the treatment of advanced solid tumors...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Pimasertib Hydrochloride in Solid Tumor
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pimasertib Hydrochloride in Solid Tumor Drug Details: Pimasertib hydrochloride is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Elamipretide Hydrochloride in Dry (Atrophic) Macular Degeneration
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Elamipretide Hydrochloride in Dry (Atrophic) Macular Degeneration Drug Details: Elamipretide hydrochloride (Bendavia) is under development...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Elamipretide hydrochloride in Duchenne Muscular Dystrophy
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Elamipretide hydrochloride in Duchenne Muscular Dystrophy Drug Details: Elamipretide hydrochloride (Bendavia) is under development for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Elamipretide hydrochloride in Dry (Atrophic) Macular Degeneration
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Elamipretide hydrochloride in Dry (Atrophic) Macular Degeneration Drug Details: Elamipretide hydrochloride (Bendavia) is under development...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Elamipretide Hydrochloride in Friedreich Ataxia
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Elamipretide Hydrochloride in Friedreich Ataxia Drug Details: Elamipretide hydrochloride (Bendavia) is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Elamipretide Hydrochloride in Geographic Atrophy
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Elamipretide Hydrochloride in Geographic Atrophy Drug Details: Elamipretide hydrochloride (Bendavia) is under development for the...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.